Afamelanotide Afamelanotide , sold under the brand name Scenesse , is a medication used to prevent phototoxicity and to reduce pain from light exposure for people with erythropoietic protoporphyria, [1] [2] [4] a rare form of genetic sun sensitivity
In a clinical trial of more than 3,000 adults with obesity, participants who received the highest dose of orforglipron, 36 milligrams, lost 11.2% of their body weight -- about 25 pounds on average -- over more than 16 months
Blue Cross Complete has served Medicaid members since 2007.
What were the results of the SUSTAIN-7 trial
Sharing a 94% structural homology with native human GLP-1, Semaglutide is distinguished by three modifications: 1) amino-acid substitutions at position 8 (alanine to -aminoisobutyric acid or Aib) and position 34 (lysine to arginine), and acylation of the lysine in position 26 with a spacer consisting of two 8-amino-3,6-dioxaoctanoic acid (ADO) moieties, a glutamic acid moiety, and a C-18 fatty di-acid side chain (Lau et al., 2015)